<DOC>
	<DOCNO>NCT03072576</DOCNO>
	<brief_summary>Consenting adult present sign symptom compatible pulmonary tuberculosis interview demographic medical information , ask provide 3-4 expectorate sputum specimen . In study laboratory , sputum test use conventional investigational diagnostic test tuberculosis rifampin resistance .</brief_summary>
	<brief_title>Accuracy Feasibility Xpert Ultra</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<criteria>Case Detection Group Age 18 year ; Provision inform consent ; Willingness provide 4 sputum specimen enrolment ; Willingness study followup visit approximately 42 70 day enrolment Clinical suspicion pulmonary TB ( include cough ≥2 week least 1 symptom typical TB ) Receipt dose TB treatment within 6 month prior enrolment Participants , time enrolment , followup visit judge poorly feasible ( e.g . individual plan relocate ) DrugResistant TB Group Age 18 year ; Provision inform consent ; Willingness provide 4 sputum specimen enrolment ; Nonconverting pulmonary TB case ( category I category II failure ) multidrug resistant ( MDR ) suspect* ( base World Health Organization definition ) , i.e . least one following : ) retreatment case , ii ) active TB case MDRcontacts iii ) patient high risk MDRTB determine local program ( e.g . prisoner ) • none</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Diagnosis</keyword>
	<keyword>Xpert MTB/RIF</keyword>
	<keyword>Ultra Xpert MTB/RIF</keyword>
</DOC>